Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion

Completed 615 enrolled Gynuity Health Projects

Non-randomizedParallel-groupOpen-labelHealth-services research

Summary

The primary aim of this study is to assess the acceptability of home-use mifepristone for termination of pregnancy among women who choose it and their providers. The investigators' secondary aims are to assess rates of follow-up, adherence, efficacy, complications, lost productivity, and to estimate the minimum proportion of women who choose home-use over clinic use of mifepristone.

Timeline

Start: 2009-05
Primary completion: 2011-02
Completion: 2011-02

Publications

Conkling K, Karki C, Tuladhar H, Bracken H, Winikoff B. A prospective open-label study of home use of mifepristone for medical abortion in Nepal. Int J Gynaecol Obstet. 2015 Mar;128(3):220-3. doi: 10.1016/j.ijgo.2014.09.022. Epub 2014 Nov 27.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Mifepristone	Small molecule	200 mg	Oral

Indications

No indication recorded.